These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 16135136
1. Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung. Patton JS. Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S5-8. PubMed ID: 16135136 [Abstract] [Full Text] [Related]
6. Clinical evaluation of inhaled insulin. Mastrandrea LD, Quattrin T. Adv Drug Deliv Rev; 2006 Oct 31; 58(9-10):1061-75. PubMed ID: 17070613 [Abstract] [Full Text] [Related]
7. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term. Prescrire Int; 2006 Dec 31; 15(86):203-9. PubMed ID: 17165235 [Abstract] [Full Text] [Related]
8. New ways of insulin delivery. Heinemann L. Int J Clin Pract Suppl; 2010 Feb 31; (166):29-40. PubMed ID: 20377662 [Abstract] [Full Text] [Related]
9. Unlocking the opportunity of tight glycaemic control. Far from goal. Del Prato S. Diabetes Obes Metab; 2005 Nov 31; 7 Suppl 1():S1-4. PubMed ID: 16135133 [Abstract] [Full Text] [Related]
10. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: safety. Brain JD. Diabetes Obes Metab; 2005 Nov 31; 7 Suppl 1():S14-8. PubMed ID: 16135134 [Abstract] [Full Text] [Related]
11. Pulmonary delivery of insulin by liposomal carriers. Huang YY, Wang CH. J Control Release; 2006 Jun 12; 113(1):9-14. PubMed ID: 16730838 [Abstract] [Full Text] [Related]
12. Unlocking the opportunity of tight glycaemic control. Promise ahead: the role of inhaled insulin in clinical practice. Heine RJ. Diabetes Obes Metab; 2005 Nov 12; 7 Suppl 1():S19-23. PubMed ID: 16135135 [Abstract] [Full Text] [Related]
13. Inhaled insulin: new technology, new possibilities. Bellary S, Barnett AH. Int J Clin Pract; 2006 Jun 12; 60(6):728-34. PubMed ID: 16805759 [Abstract] [Full Text] [Related]
14. Noninjectable methods of insulin administration. Cernea S, Raz I. Timely Top Med Cardiovasc Dis; 2006 Nov 01; 10():E29. PubMed ID: 17136235 [Abstract] [Full Text] [Related]
15. Smoking enhances absorption of insulin but reduces glucodynamic effects in individuals using the Lilly-Dura inhaled insulin system. Wise S, Chien J, Yeo K, Richardson C. Diabet Med; 2006 May 01; 23(5):510-5. PubMed ID: 16681559 [Abstract] [Full Text] [Related]
16. [Biotechnological and administration innovations in insulin therapy]. Verge D. Med Sci (Paris); 2004 Nov 01; 20(11):986-98. PubMed ID: 15525494 [Abstract] [Full Text] [Related]
17. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Laube BL. Respir Care; 2005 Sep 01; 50(9):1161-76. PubMed ID: 16122400 [Abstract] [Full Text] [Related]
18. Insulin-micro- and nanoparticles for pulmonary delivery. Klingler C, Müller BW, Steckel H. Int J Pharm; 2009 Jul 30; 377(1-2):173-9. PubMed ID: 19446621 [Abstract] [Full Text] [Related]
19. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action. Henkin RI. Nutrition; 2010 Jan 30; 26(1):33-9. PubMed ID: 20005465 [Abstract] [Full Text] [Related]
20. [Inhaled insulin: a new route in the optimisation of glucose regulation]. Luik PT, Veneman TF. Ned Tijdschr Geneeskd; 2006 Apr 15; 150(15):833-8. PubMed ID: 16676512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]